Verastem, Inc. (LON:0LOV)
London · Delayed Price · Currency is GBP · Price in USD 9.52
-0.07 (-0.74%)
At close: Sep 12, 2025
Verastem Employees
Verastem had 78 employees as of December 31, 2024. The number of employees increased by 5 or 6.85% compared to the previous year.
Employees
78
Change (1Y)
5
Growth (1Y)
6.85%
Revenue / Employee
20.00K GBP
Profits / Employee
-1.56M GBP
Market Cap
433.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 78 | 5 | 6.85% |
| Dec 31, 2023 | 73 | 16 | 28.07% |
| Dec 31, 2022 | 57 | 9 | 18.75% |
| Dec 31, 2021 | 48 | 0 | - |
| Dec 31, 2020 | 48 | -87 | -64.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
Verastem News
- 4 weeks ago - Balyasny Asset Management L.P. Increases Stake in Verastem Inc - GuruFocus
- 5 weeks ago - Verastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics' Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lung Cancer - Business Wire
- 5 weeks ago - Verastem, Inc. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Verastem, Inc. (VSTM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Verastem climbs on Q2 beat as new ovarian cancer drug boosts topline - Seeking Alpha
- 6 weeks ago - Verastem Non-GAAP EPS of -$0.63 beats by $0.11, revenue of $2.14M beats by $1.02M - Seeking Alpha
- 6 weeks ago - Verastem Oncology Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates - Business Wire
- 7 weeks ago - Verastem Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire